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Pneumonic pasteure llosis is a common respiratory d isease of goats 
and sheep throughout the world , including Malaysia . In Malaysia,  Pasteurella 
haemolytica A2 is most commonly isolated from cases of pneumonic 
pasteurel losis in  sheep and goats fol lowed by Pasteurella haemolytica A 7 
and A9 . 
Vaccination has been used widely to control the d isease with 
uncertain success rate. The reasons for vaccination failure in the field were 
due to incompatible strains, unsuitable antigen as vaccine component and 
improper vaccination prog ramme. Therefore, the attentions have been 
focused on the concept of a novel vaccine, which includes subu nit vaccine. 
x 
The outer membrane prote ins (OMPs) of Pasteurella haemolytica A2, A7 
and A9 have been extracted using sod ium dodecyl sulfate-polyacrylamide gel  
electrophoresis (SOS-PAGE). Each serotype gave two to three major 
polypeptide bands with some minor bands. Immunoblotting,  carried out using 
homologous and heterologous antisera against the OMPs from a l l  serotypes . 
The results showed that the 30 kOa band of Pasteurella haemolytica A7 could 
be recognised by all antisera , and was th us concluded as the major and 
common immunogen . 
The in vivo tests using the OMPs of the three serotypes revealed that 
sheep injected with the 1 00 /lg OMP followed by a booster dose on day 21 
showed h ighest antibody level on day 28 post-injection . Animals vaccinated 
with the OMP of Pasteurella haemolytica A7 showed good immune response 
upon challenge with sign ificantly (p<0.05) less severe lung lesions regardless 
whether chal lenged with Pasteurella haemolytica serotype A2, A7 or A9 . Those 
animals vaccinated with the OMP of Pasteurella haemolytica A2 failed to protect 
against challenge with l ive Pasteurella haemolytica A9 while those vaccinated 
with the OMP of Pasteurella haemolytica A9 failed to protect against challenge 
with l ive Pasteurella haemolytiva A2 and A7. It is concluded that the O MP of 
Pasteurella haemolytica A7 provides cross-protection to challenges uSing live 
Pasteurella haemolytica A2, A7 and A9 . Thus, the OMP of Pasteurella 
haemolytica A7, particu larly the 30 kOa, cou ld be the best cand idate for a 
subunit vaccine against pneumonic pasteurel losis in sheep. 
XI 
Abstrak tesis yang dkemukakan kepada Senat Universiti Putra Malaysia sebagai 
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Oleh 
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Pasteurelosis pneumonia merupakan penyakit pernafasan kambing dan 
bebiri yang lazim di serata dunia, termasuk Malaysia. Di Malaysia, Pasteurella 
haemolytica A2 adalah yang paling kerap diasingkan daripada kes pasteurelosis 
pneumonia kambing dan bebiri, diikuti oleh Pasteurella haemolytica A7 da n A9 
Pemvaksinan dig una dengan meluas untuk mengawal penyakit inl  tanpa 
kesan yang memuaskan .  Sebab utama kegagalan pemvaksinan adalah kerana 
ketidak-keterampilan strain ,  ketidak-sesuaian antigen sebagai komponen vaksin 
dan program pemvaksinan  yang kurang memuaskan.  Maka , penumpuan telah 
dilakukan terhadap konsep vaksin nove l ,  yang termasuk vaksin subu nit 
xii 
Protein selaput luar (OMP) Pasteurella haemolytica A2, A7 dan A9 telah 
diasing dengan menggunakan sodium dodecil sulfat-gel elektroforesis 
pol iakrilamide (SOS-PAGE). Tiap-tiap serotip menghasi lkan d ua hingga tiga 
pol ipeptida major dengan beberapa gelung minor. Pemblotan imun yang 
d i lakukan menggunakan antiserum homolog us dan heterologus terhadap OMP 
kesemua serotip. Keputusan menunjukkan bahawa 30 kOa Pasteurella 
haemolytica A7 merupakan imunogen major dan lazim. 
Uj ian in vivo menggunakan OMP ketiga-tiga serotip menunjukkan yang 
bebiri yang d isuntik dengan 1 00 Ilg OMP dan diransang lag i  pada hari ke-2 1 
mempunyai tahap antibodi yang paling tinggi pada hari ke 28 selepas suntikan.  
Haiwan yang d isuntik dengan OMP Pasteurella haemolytica A7 menunjukkan 
gerakbalas imun yang baik dengan keterukan lesi peparu yang kurang (p<0. 05) 
sarna ada d icabar dengan Pasteurella haemolytica serotip A2, A7 atau A9. 
Haiwan-haiwan yang disuntik dengan OMP Pasteurella haemolytica A2 gagal 
melindung terhadap cabaran oleh Pasteurella haemolytica A9 sementara yang 
disuntik dengan OMP Pasteurella haemolytica A9 gagal melindung cabaran oleh 
Pasteurella haemolytiva A2 dan A7. Maka kesimpu lannya menunjukkan 
bahawa OMP Pasteurella haemolytica A7 memberi perl indungan si lang 
terhadap cabaran oleh Pasteurella haemolytica A2 dan A9 . Maka, OMP 
Pasteurella haemolytica A7, terutama sekal i  30 kOa , merupakan calon pal ing 





Pneumonic pasteurel losis is a common respiratory d isease of goats 
and sheep (Gilmour, 1 993). The disease was first reported early this century 
when enzootic pneumonia was reported in sheep in England and Wales 
(Montgomorie et a/., 1 938) . Pasteurella haemo/ytica biotype A is the most 
common isolate from the pneumonic lungs of affected animals although 
Pasteurella mu/tocida types A and 0 are occasionally isolated (Gi lmour et a/., 
1 991 ) .  
Pasteurella haemo/ytica has been recognised as a component of the 
normal flora of the nasopharynx and tonsils of apparently healthy animals of 
various species including sheep (Dungworth , 1 985). Lambs are thoug ht to 
acquire Pasteurella haemolytica in their nasal mucosa after birth, presumably 
by contact with the ewe (Shreeve and Thompson , 1 970) . Following stressful 
conditions,  Pasteurella haemo/ytica prol iferates in  the upper respiratory tract 
and a great n umber of the organisms are inhaled into the lungs (Gonzalez 
and Maheswaran , 1 99 1 )  lead ing to fibrinous pneumonia (Zamri-Saad , 1 988; 
Jericho, 1 989) and death (Zamri-Saad et a/., 1 983). 
1 
2 
Vaccination is the most common method of control l ing the d isease 
worldwide (Mosier, 1 993). Although the need for an efficacious Pasteurella 
haemolytica vaccine for goats and sheep is apparent, none of the 
commercial ly avai lable pasteurel la vaccines are able to p rovide good 
protection in the field (Wan Mohamed et aI., 1 988; Zamri-Saad et al., 1 989a , 
b; Jamalud in ,  1 993). Recently, a new pasteurella spray vaccine was 
developed , which is easy to administer and provides good protection against 
experimental chal lenge (Effendy et a/. , 1 998a, b) . The vaccine, however, 
fai l .ed to provide cross-protection against Pasteurella haemolytica A7 and A9 
(Zamirah,  1 998).  
Several antigens with high potential as components of a subunit 
vaccine have been identified in Pasteurella haemolytica. These include the 
iron-regu lated proteins ( IRPs) (Donach ie and Gi lmour, 1 988; Ogunnariwo 
and Schryvers , 1 990; Gi lmour et aI. , 1 991) ,  the outer membrane proteins 
(OM Ps) (Donachie et al., 1 984) ,  the l ipopolysaccharide (LPS) (Fenwick, 
1 990), the capsu lar polysaccharide (CPS) (Czuprynski et aI., 1 991  a) and the 
leukotoxin (LktA) (Lo et aI. , 1 987) . The antigen ic simi larity between the 
toxins produced by d ifferent serotypes of Pasteurella haemolytica has been 
shown to result  in the production of cross-neutral izing antibodies (Shewen 
and Wilkie , 1 988). This cross-neutral izing effect offers an antigenic 
advantage in the formu lation of a subunit pasteurella vaccine (Fraser et al., 
3 
1982). However, the toxins of Pasteurella haemolytica A2, which is the most 
commonly isolated serotype from pneumonic lungs of sheep and goats, do 
not posses cross-neutra l ization with other serotypes (Gilmour, 1 993) . Th is 
has lead to the formu lation of many commercia l ly available polyvalent 
pasteurel la vaccines, which were aimed at provid ing a wide scope of 
protection (Gi lmour et al. , 1 979) . The OMP's of Pasteurella haemolytica A2 , 
A7 and A9 h ave not been analysed for their abil ity to evoke cross­
neutralization and cross-protection. In consideration of the potential of 
OMP's as a vaccine candidate (Confer, 1 993), the objectives of this research 
project were to: 
1 .  determine the OMPs profi les of Pasteurella haemolytica A2, A7 and A9 
isolates using sod ium dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE).  
2. determine the antigen icity of the OMPs of Pasterurella haemolytica A2, 
A7 and A9 isolates using Western blotting against homologous and 
heterologous antisera. 
3. determine the in vivo immunogenicity of the OMPs of Pasteurella 
haemolytica A2, A7 and A9 and to assess their potential as a component 
of a subunit pasteurella vaccine in goats/sheep. 
CHAPTER II 
LITERATURE REVIEW 
Pneumonic pasteurel losis 
Pneumonic pasteurel losis is an important respiratory disease of cattle, 
sheep and goats throughout the world. It is usually caused by Pasteurella 
haemolytica biotype A. Pasteurella haemolytica A 1 is the most common 
causative agent in cattle while Pasteurella haemolytica A2 is the agent 
frequently isolated from sheep and goats (Gilmour, 1 993). The d isease 
occurs in sheep of all ages. In young animals of less than 3 weeks old ,  the 
disease is hyperacute with generalised infection , whi le animals between 3 to 
12 weeks of age suffer from acute infection characterised by pleu risy and 
pericarditis for 2-3 days (Gilmour, 1 993) . 
Pasteurella haemolytica is part of the nasal bacterial flora of sheep 
and goats . The prevalence and numbers of Pasteurella haemolytica in the 
nasopharynx increase during stressfu l cond itions and predispose the host to 
pneumonic pasteurel losis (Gilmour, 1 993). There are several pred isposing 
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factors that lead to the development of this disease. The predisposing 
factors fall into two main categories. The first category is the management 
and environment factor, in  which proof is circumstantial (Jasni  et al. , 1 990; 
Zamri-Saad et aI. , 1 99 1 ;  Gilmour, 1 993) .  The second category is the 
infectious agents such as the parainfluenza virus type 3 (Gi lmour  et al. , 
1 99 1 ) , herpesvirus (BuddIe et al. , 1 990) and Haemonchus confortus (Zamri-
, 
Saad ef aI. , 1 994) . 
Upon entrance of a large number of Pasteurella haemolytica into the 
lungs, they produce leukotoxin ,  which is either toxic to the a lveolar 
macrophage or has the abi l ity to reduce the efficiency of phagocytosis by 
neutrophi lic leucocytes and alveolar macrophages. The adverse effects of 
leukotoxin on i nflammatory cells of the lungs enhance colon isation of 
Pasteurella haemolytica onto the alveolar epithel ium (Effendy et al. , 1 998a) 
and min imise phagocytosis of bacterial cel ls by the a lveolar macrophage 
(Zamri-Saad et aI. , 1 996; Maswati , 1 998) . Fol lowing successful colonisation 
onto the lung surface, the bacteria enter the pneumocytes causing the 
formation of cytoplasmic vacuoles and necrosis of the affected pneumocytes 
(Maswati , 1 998) .  At the same time, endotoxin ( l ipopolysaccharide) of 
Pasteurella haemolytica causes severe lesions, particularly on the pu lmonary 
blood vessels (Heng et al. , 1 996) . Typical fibr inous bronchopneumonia 
comprised of fibrin and the presence of numerous macrophages and oat cel ls 
In the alveolar space has been reported in animals infected with both 
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Pasteurella haemolytica and Pasteurella multocida (Zamri-Saad, 1987; 
Loganathan and Chandrasekaran, 1 992). 
There are no clear cl in ical signs for pneumonic pasteurel losis. Stud ies 
revealed that signs of respiratory tract infection, such as coughing, nasal 
d ischarge and dyspnoea are poorly correlated with the severity of lung 
lesions fol lowing infection by Pasteurella haemolytica compared to 
Pasteurella multocida (Zamri-Saad et a/., 1 996; Effendy et a/., 1 998b). The 
mortal ity rate, however, ranges from 1 0  to 30% (Jasni  et a/., 1 990; Fatimah et 
a/., 1 992; Gi lmour, 1 993) .  
In Malaysia, since Pasteurella haemolytica was confirmed a s  the most 
common cause of pneumonia in sheep and goats with a 40 to 43% isolation 
rate fol lowed by Pasteurella multocida with 24 to 48% isolation rate (Sheikh­
Omar et a/., 1 989, 1 993), the disease was considered endemic (Saharee and 
Fatimah, 1 993) .  The disease has become increas ingly important (Jamaludin, 
1 993) fol lowing attempts to increase the sheep population in Malaysia in 
1 987 (Hadi, 1 988) and is recognised as one of the major ca uses of death of 
sheep and goats in  th is country (Zamri-Saad et a/., 1987; Jasni et aI., 1 990; 
Fatimah et al., 1 992). 
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Pasteurella haemo/ytica 
Pasteurella haemolytica is a Gram-negative bacterium,  which has 
been identified as the aetiological agent of bovine pneumonic pasteurellosis 
or shipping fever and ovine pneumonic pasteurel losis and septicaemic 
pasteurel losis (DeAlwis, 1993) . These d iseases have been known to 
produce significant economic losses (Gilmour, 1993). Pasteurella 
haemolytica comprises two b iotypes; A and T, based on their fermentation of 
arabinose and trehalose . Of the two b iotypes of Pasteurella haemolytica, 16 
serotypes were identified , based on their soluble capsu lar antigen 
(Biberstein, 1978; Fodor et al. , 1988) . Since Pasteurella haemolytica biotype 
T ferments trehalose, it has been propo�ed that the b iotype be re-named 
Pasteurella trehalosi (Sneath and Stevens, 1990) . 
Pasteurella haemolytica biotype A comprises 13 serotypes while 
Pasteurella haemolytica biotype T comprises 3 serotypes (Ad lam, 1989; 
Younan and Fodor, 1995) .  The serotypes of Pasteurella haemolytica biotype 
A include A1, A2, A5, A6 , A7, A8 , A9, A11 ,  A12, A13, A14, A16, and A17. 
Frederiksen (1973) discovered that Pasteurella haemolytica serotype A 11 
isolates did not fit easily into biotype A and proposed a third biotype to 
accommodate them. In addition to recognised serotypes , approximately 10% 
of the iso lates of Pasteurella haemolytica obtained from cattle and sheep are 
untypable (Fraser et al. , 1982; Quirie et al. , 1 986) .  Although some untypable 
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isolates are found to be closely related to those of biotype A, others 
represent d ifferent species (Mutters et a/., 1986; Davies et a/., 1996). 
Pasteurella haemolytica A 1 is the predominant serotype recovered 
from cattle with pneumonic pasteurellosis. Serotype A2 is less frequently 
isolated from pneumonic lungs of cattle even though it is often isolated from 
the naso-pharynx of healthy animals (Frank, 1 989). Pasteurella haemolytica 
serotype A2, however , is the predominant serotype recovered from cases of 
pneumonic pasteurellosis in sheep while serotype A 1 is less frequently 
isolated from this animal species (Gilmour and Gilmour ,  1 989; Bahaman et 
aI., 1991; Mohamad et a/., 1 993). 
The Potential Protective Antigens of Pasteurella haemo/ytica 
Outer Membrane Proteins (OMPs) 
Separation of the inner and outer membranes of Gram-negative 
bacteria has been carried out successfully using several methods (Hancock, 
1991). Both inner and outer membrane structures are relatively rich in 
proteins. The outer membrane is composed of a smal l  number of major 
proteins; four  to five prominent proteins in some bacterial species (Hancock, 
1991 ). 
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Studies aimed at determining immunogenic components of 
Pasteurella haemolytica and Pasteurella multocida have focused main ly on 
the outer membrane prote ins. This is because the outer membra ne of Gram­
negative bacteria is the cel lu lar component, which is in d i rect contact with the 
host (Squire et a/., 1 984 ; Owen ,  1 99 1 ) . It has been demonstrated to be 
involved in the protection against the bacteria itself (Squire et a/. , 1 984; 
Owen,  1 99 1 ) . The s ize of the outer membrane is approximately 1 0  nm in  
diameter and its structure ,  composition and functions are different from the 
cel ls' cytoplasm or the inner membrane. The membrane is a fully 
asymmetrical bi layer, composed of the outer membrane proteins 
(approximate ly 44%) , phosphol ip ids (approximately 1 3%) and carbohydrate 
polymers (approximate ly 43%) (Squire et a/. , 1 984 ; Adlam , 1 989; Owen ,  
1 991 ) .  The outer layer of the OMP contains l ipopolysaccharide (LPS) 
whereas the inner layer is composed largely of phosphol ipid and the acyl 
chains of lipoproteins (Squire et a/. , 1 984; Owen ,  1 991 ). The major OMPs 
are limited in number and range between three to eight protein bands , 
present in high copy numbers between 50,000 to 750,000 copies/ce l l  
(Donachie et a/., 1 984; Squire et a/. , 1 984). 
Research on the outer membrane has greatly contributed to an 
understanding of the pathogenesis of many Gram-negative bacterial 
infections (Beachey, 1 981 ;  Squire et aI. , 1 984; Lu et aI., 1 988; Botcher et a/ . ,  
1 99 1 ;  Sherman et a/ . ,  1 991 ; Weiser and Gotsch lich , 1 99 1 ) . Many of these 
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studies have demonstrated that the major OMPs (MOMP), which represent 
the most abundant OMP in sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE),  are protective and showed some degree of 
antigenic heterogeneity among d ifferent strains (Munson et al., 1 983; Virj i  et 
al., 1 986) . One of the major outer membrane proteins (MOMPs) is cal led 
porin ,  which is identifiable when solubi l ized in sample buffer at 3rC and 
appears at relatively low electrophoretic mobil ity (Lugtenberg and Van 
Alphen, 1 983) . Another MOMP is known as the heat-mod ifiable protein 
(OmpA), and is classically recogn ised by a current charge in i ts mobil i ty on 
SDS-PAGE when solubilized in sample buffer at a different temperature. 
When heat-modifiable OMP is solubilized at 88°C or less, i t  showed a 
relatively low molecular mass, whereas the apparent molecular mass 
increased when it was solubi l ized at 1 00°C (Hancock and Carey, 1 979; 
Tagawa et al., 1 993a). The heat-modifiable OMP is necessary for the 
maintenance of the structural integrity of the cel l  envelope (Sonntag et al., 
1 978) ,  bacterial conjugation (Schweizer and Herning,  1 977), bacteriophage 
attachment (Datta et al., 1 977) and porin activity (Sugawara and Nika ido, 
1992). The antigenicity of the heat-modifiable OMP and its composition are 
conserved during the evolution among the Gram-negative bacteria (Beher et 
aI. , 1 980). The heat-mod ifiable OMP also determines the res istance of the 
organism to complement-mediated serum ki l l ing (Weiser and Gotsch l ich , 
1 991 ). Bacterial OMPs are important for attachment to the host cells and for 
the transport of materials th rough the membrane. On the other hand,  
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antibod ies against the OMPs of Gram-negative bacteria are expected to 
provide protection against infection by these Gram-negative microorganisms 
(Kuusi et al. , 1 979; Zol linger et al. , 1 979; Winter et al. , 1 983; Hedstrom et al. , 
1 984) .  I n  fact, the importance of using aMPs to stimulate immunity has been 
shown for many Gram-negative bacteria (Dubray and Bezard , 1 990; Adamus 
et al. , 1 980). 
Ali ( 1 992) and McCluskey ( 1 994) described the variations in LPS and 
aMP profi les of a small number of isolates of Pasteurella haemolytica 
serotypes A 1 and A2, which were associated with pneumonic pasteurel losis. 
Sodium dodecyl su lfate-polyacrylamide gel electrophoresis and Western 
b lotting techniques have been widely used to analyse the aMPs and LPS 
profiles to determine strain variations, epidemiology and virulence of bacterial 
pathogens. The aMP patterns in SDS-polyacrylamide gels have been used 
to differentiate both human (Loeb and Smith , 1 980; Mocca and Frasch, 1 982; 
Achtman et al. , 1 983; Blaser et al. , 1 983; Odumeru et aI., 1 983) and 
veterinary (Lugtenberg et al. , 1 984 ; Rapp et aI. , 1 986; Davies , 1 99 1 )  
pathogens. Analyses of both OMP and LPS profi les by SDS-PAGE, 
however, are less frequently carried out even though such study is performed 
routinely on Escherichia coli (Achtman et al. , 1 986) and Pasteurella 
multocida (Lugtenberg et al. , 1 984). The Western blotting has been used 
successfu l ly on both Gram-negative (Bolstad et aI. , 1 990; Hasman and 
